Growth Metrics

Zepp Health (ZEPP) Current Deferred Revenue (2016 - 2025)

Zepp Health has reported Current Deferred Revenue over the past 10 years, most recently at $4.7 million for Q4 2025.

  • For Q4 2025, Current Deferred Revenue fell 5.7% year-over-year to $4.7 million; the TTM value through Dec 2025 reached $4.7 million, down 5.7%, while the annual FY2025 figure was $4.7 million, 5.7% down from the prior year.
  • Current Deferred Revenue for Q4 2025 was $4.7 million at Zepp Health, down from $4.9 million in the prior quarter.
  • Over five years, Current Deferred Revenue peaked at $8.6 million in Q4 2022 and troughed at $661612.6 in Q4 2021.
  • A 5-year average of $5.3 million and a median of $4.9 million in 2024 define the central range for Current Deferred Revenue.
  • Biggest five-year swings in Current Deferred Revenue: tumbled 91.53% in 2021 and later skyrocketed 1199.84% in 2022.
  • Year by year, Current Deferred Revenue stood at $661612.6 in 2021, then skyrocketed by 1199.84% to $8.6 million in 2022, then dropped by 12.82% to $7.5 million in 2023, then plummeted by 34.03% to $4.9 million in 2024, then decreased by 5.7% to $4.7 million in 2025.
  • Business Quant data shows Current Deferred Revenue for ZEPP at $4.7 million in Q4 2025, $4.9 million in Q4 2024, and $7.5 million in Q4 2023.